Orthofix to Present at Ladenburg Thalmann 2017 Healthcare Conference

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a diversified, global medical device company, today announced that President and Chief Executive Officer Brad Mason will present at the Ladenburg Thalmann 2017 Healthcare Conference in New York, NY on Tuesday, September 26, 2017 at 3:30 p.m. ET.

A live audio webcast will be available on the Company’s website at ir.orthofix.com/events.cfm.

About Orthofix

Orthofix International N.V. is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, Texas, the Company has four strategic business units: BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the Company's sales representatives and distributors. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as Brown University, Sinai Hospital of Baltimore, Cleveland Clinic, Texas Scottish Rite Hospital for Children, and the Musculoskeletal Transplant Foundation. For more information, please visit www.orthofix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170919005484/en/

Orthofix International N.V.
Investor Contact:
Mark Quick, 214-937-2924
[email protected]
or
Media Contact:
Denise Landry, 214-937-2529
[email protected]

Source: Orthofix International N.V.

You May Also Be Interested In

• Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma
• Spatial Intelligence Company, Schemata Expands Cybersecurity Team with Search for Next Security Engineer
• Cantor Commences Institutional Block Trading in Prediction Markets